Skip to main content

COVID 19 Updates from RheumNow

Social

RheumNow Podcast Now UP – Steroids, IVIG & the Vaccine. How to handle COVID19 Vaccine issues, IL-6 inhibition in COVID, Comorbidites in RA, IVIG in dermatomyositis, & more... https://t.co/f0wWTm2kV5

Dr. John Cush @RheumNow ( View Tweet )

4 years 3 months ago
New Download Available on COVID-19 & mRNA Vaccines https://t.co/mvmn17Fl3B https://t.co/ceICzbDZi5
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
QD Clinic - What to do After COVID Vaccination https://t.co/25RcMOdAkK https://t.co/EWnYJGNqvY
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
Hydroxychloroquine Shortage During COVID-19--According to a recent report in Annals of Rheumatic Disease, public enthusiasm for hydroxychloroquine (HCQ) created significant access issues for rheumatic patients in the early phases of the COVID-19 pandemic. https://t.co/h9hrAfv9xo https://t.co/IVSYCueK2h
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
National Psoriasis Foundation Task Force updated their COVID-19 guidance statements. Including Guidance 4.6, stating PsA pts who receive a mRNA-COVID vaccine should continue their biologic or oral therapies as they manag of their psoriatic disease https://t.co/byujtDET33

Dr. John Cush @RheumNow ( View Tweet )

4 years 3 months ago
After your 2 doses of COVID vaccine, YES you need to continue to wear a mask, cont. hand washing & social distancing - so as to continue to protect yourself and others. While vaccinated you can still become infected and spread infection. https://t.co/TkcSNx0hF1

Dr. John Cush @RheumNow ( View Tweet )

4 years 3 months ago
A oatint infected with COVID-19- Yes they should get vaccinated ~90days after infection has resolved.Antibody testing is not needed before you are vaccinated. Evidence suggests that reinfection is uncommon in the 90 days after initial infection. https://t.co/TkcSNx0hF1.

Dr. John Cush @RheumNow ( View Tweet )

4 years 3 months ago
Preprint results of the REMAP-CAP trial in the UK shows that IL-6 inhibitors, when given within 24 hrs of ICU entry for COVID-19, lowers mortality rate by 36%. Hosp mortality in 353 TCZ was 28%, 48 sarilumab was 22% in 402 controls was 36%. https://t.co/fkjOz99t0l

Dr. John Cush @RheumNow ( View Tweet )

4 years 3 months ago
ACR Convergence 2020 Late Breaking Abstracts available from the ACR "Spotlight" slide give away. 10 slides on COVID, Tyk2 in PsA, FAST febuxostat study, Tofa in AS and novel drugs for SLE and PSS https://t.co/DvcDyusCUR

Dr. John Cush @RheumNow ( View Tweet )

4 years 3 months ago
RheumNow Podcast is up! Benlysta safety, HCQ lowers thromboses, HCQ adherence, Telemedicine, Actemra in COVID,, 2021 looking forward and zoomatology! Watch it here>> https://t.co/PtfEUPB1hc or listen to podcast on Apple> https://t.co/FHJv01AAbC or Android>https://t.co/Iylluqqeej

Dr. John Cush @RheumNow ( View Tweet )

4 years 3 months ago
×